Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WC4Y
|
|||
| Drug Name |
FCX-007
|
|||
| Indication | Dystrophic epidermolysis bullosa [ICD-11: EC32; ICD-10: Q81.2] | Phase 1/2 | [1] | |
| Company |
Fibrocell Science Exton, PA Intrexon Germantown, MD
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.